Long-term physical, mental and social health effects of COVID-19 in the pediatric population: A sco** review

M Borel, L **e, O Kapera, A Mihalcea, J Kahn… - World Journal of …, 2022 - Springer
Background The majority of coronavirus disease 2019 (COVID-19) symptom presentations
in adults and children appear to run their course within a couple of weeks. However, a …

Gastrointestinal perspective of coronavirus disease 2019 in children—an updated review

A Assa, MA Benninga, O Borrelli… - Journal of Pediatric …, 2021 - journals.lww.com
Gastrointestinal symptoms are common findings in children with severe acute respiratory
syndrome coronavirus 2 infection, including vomiting, diarrhoea, abdominal pain, and …

Acute covid-19 and multisystem inflammatory syndrome in children

JH Rubens, NP Akindele, MM Tschudy… - Bmj, 2021 - bmj.com
• Consider multisystem inflammatory syndrome (MIS-C) in children presenting with fever and
abdominal symptoms—particularly if they develop conjunctivitis or rash—and refer to a …

COVID-19: Clinical manifestations and diagnosis in children

JG Deville, E Song, CP Ouellette - Up to Date, 2021 - uptodate.com
Starting in late 2019, a novel coronavirus rapidly spread throughout the world, resulting in a
global pandemic. The virus was designated severe acute respiratory syndrome coronavirus …

Severe encephalopathy associated with SARS-CoV-2 Omicron BA. 1 variant infection in a neonate

K Tetsuhara, S Akamine, Y Matsubara, S Fujii… - Brain and …, 2022 - Elsevier
Introduction The coronavirus disease 2019 (COVID-19), including the Omicron variant, is
less severe in children than in adults. To date, there has been no detailed description of …

[HTML][HTML] Risk factors for severe COVID-19 infection in Brazilian children

JV Hendler, PM do Lago, GC Müller, JC Santana… - The Brazilian Journal of …, 2021 - Elsevier
The aim of this study was to describe the epidemiological characteristics and clinical
outcome of children hospitalized with COVID-19 and identify the risk factors for severe …

Comparison of SARS-CoV-2-specific antibodies in human milk after mRNA-based COVID-19 vaccination and infection

HG Juncker, SJ Mulleners, MJ van Gils, TPL Bijl… - Vaccines, 2021 - mdpi.com
SARS-CoV-2-specific antibodies are secreted into human milk of infected or vaccinated
lactating women and might provide protection to the breastfed infant against COVID-19 …

Presentations and Outcomes Among Infants≤ 90 Days With and Without SARS-CoV-2

B Burstein, V Sabhaney, TA Florin, J **e… - …, 2024 - publications.aap.org
OBJECTIVES To compare symptoms and outcomes among infants aged≤ 90 days tested
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a broad, international …

Bacterial coinfection in young febrile infants with SARS-CoV-2 infection

S Hernández-Bou, V Trenchs, P Diego, A Seguí… - European Journal of …, 2024 - Springer
We aimed to assess the prevalence of serious bacterial infections (SBIs) in febrile infants<
90 days of age with SARS-CoV-2 infection versus SARS-CoV-2-negative febrile infants. A …

Severe acute respiratory syndrome coronavirus 2 in infants younger than 90 days presenting to the pediatric emergency department: clinical characteristics and risk of …

T Benenson-Weinberg, I Gross… - Pediatric Emergency …, 2023 - journals.lww.com
Objectives There are scant data on severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection in infants younger than 90 days. This study was designed to characterize …